SWHFX Holdings — Schwab Health Care Fund
All 86 reported holdings of Schwab Health Care Fund (SWHFX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 12.00% | $73.79M |
| Johnson & Johnson | 7.21% | $44.35M |
| AbbVie Inc | 5.87% | $36.07M |
| Merck & Co Inc | 4.37% | $26.84M |
| Gilead Sciences Inc | 3.93% | $24.15M |
| UnitedHealth Group Inc | 3.75% | $23.07M |
| Novartis AG | 2.99% | $18.36M |
| Medtronic PLC | 2.70% | $16.62M |
| Stryker Corp | 2.63% | $16.16M |
| Amgen Inc | 2.63% | $16.14M |
| Roche Holding AG | 2.38% | $14.63M |
| Gsk PLC | 2.14% | $13.16M |
| AstraZeneca PLC | 1.93% | $11.84M |
| Thermo Fisher Scientific Inc | 1.88% | $11.55M |
| Cigna Group/The | 1.86% | $11.44M |
| Boston Scientific Corp | 1.83% | $11.23M |
| Regeneron Pharmaceuticals Inc | 1.72% | $10.57M |
| Vertex Pharmaceuticals Inc | 1.67% | $10.28M |
| McKesson Corp | 1.50% | $9.25M |
| GE HealthCare Technologies Inc | 1.49% | $9.17M |
| HCA Healthcare Inc | 1.34% | $8.25M |
| Astellas Pharma Inc | 1.31% | $8.07M |
| Bristol-Myers Squibb Co | 1.20% | $7.37M |
| Steris PLC | 1.18% | $7.24M |
| Exelixis Inc | 1.15% | $7.06M |
| Cardinal Health Inc | 1.14% | $6.99M |
| Ipsen SA | 1.12% | $6.91M |
| Becton Dickinson & Co | 1.06% | $6.54M |
| United Therapeutics Corp | 1.05% | $6.47M |
| Danaher Corp | 1.02% | $6.24M |
| Abbott Laboratories | 1.01% | $6.20M |
| HealthEquity Inc | 1.00% | $6.13M |
| Hoya Corp | 0.94% | $5.79M |
| IQVIA Holdings Inc | 0.88% | $5.39M |
| ResMed Inc | 0.87% | $5.36M |
| Sanofi SA | 0.81% | $4.99M |
| Incyte Corp | 0.80% | $4.92M |
| Agilent Technologies Inc | 0.80% | $4.91M |
| IDEXX Laboratories Inc | 0.80% | $4.90M |
| BrightSpring Health Services Inc | 0.74% | $4.53M |
| Prestige Consumer Healthcare Inc | 0.69% | $4.23M |
| Veracyte Inc | 0.61% | $3.76M |
| Natera Inc | 0.60% | $3.70M |
| Koninklijke Philips NV | 0.60% | $3.68M |
| ANI Pharmaceuticals Inc | 0.56% | $3.45M |
| Smith & Nephew PLC | 0.55% | $3.40M |
| Intuitive Surgical Inc | 0.53% | $3.27M |
| Innoviva Inc | 0.49% | $3.03M |
| Ensign Group Inc/The | 0.47% | $2.89M |
| Catalyst Pharmaceuticals Inc | 0.42% | $2.57M |
| Consun Pharmaceutical Group Ltd | 0.37% | $2.26M |
| Shionogi & Co Ltd | 0.36% | $2.23M |
| Axsome Therapeutics Inc | 0.33% | $2.01M |
| Mettler-Toledo International Inc | 0.31% | $1.91M |
| Ucb SA | 0.30% | $1.85M |
| Biogen Inc | 0.28% | $1.75M |
| Fisher & Paykel Healthcare Corp Ltd | 0.26% | $1.62M |
| BioCryst Pharmaceuticals Inc | 0.26% | $1.61M |
| Zoetis Inc | 0.25% | $1.51M |
| Samsung Biologics Co Ltd | 0.25% | $1.51M |
| Chugai Pharmaceutical Co Ltd | 0.24% | $1.49M |
| Asahi Intecc Co Ltd | 0.24% | $1.47M |
| Mirum Pharmaceuticals Inc | 0.23% | $1.43M |
| Ambea AB | 0.23% | $1.43M |
| 10X Genomics Inc | 0.23% | $1.43M |
| BioMarin Pharmaceutical Inc | 0.23% | $1.43M |
| Madrigal Pharmaceuticals Inc | 0.23% | $1.40M |
| Elevance Health Inc | 0.22% | $1.38M |
| Merit Medical Systems Inc | 0.22% | $1.34M |
| Jazz Pharmaceuticals PLC | 0.21% | $1.29M |
| Novo Nordisk A/S | 0.21% | $1.27M |
| DENTSPLY SIRONA Inc | 0.19% | $1.19M |
| Aurinia Pharmaceuticals Inc | 0.19% | $1.16M |
| Pfizer Inc | 0.19% | $1.15M |
| Convatec Group PLC | 0.14% | $862.36K |
| Medpace Holdings Inc | 0.13% | $820.57K |
| Neurocrine Biosciences Inc | 0.13% | $816.35K |
| AnaptysBio Inc | 0.13% | $784.75K |
| Maximus Inc | 0.12% | $761.19K |
| Galenica AG | 0.12% | $743.27K |
| Amneal Pharmaceuticals Inc | 0.11% | $654.62K |
| Hugel Inc | 0.11% | $649.01K |
| Bridgebio Pharma Inc | 0.10% | $617.38K |
| Xeris Biopharma Holdings Inc | 0.05% | $313.85K |
| Elekta AB | 0.05% | $290.17K |
| Livzon Pharmaceutical Group Inc | 0.04% | $223.99K |
SWHFX overview: performance, fees, allocation and SEC filings